PartnershipUpdated on 10 April 2026
R&D collaboration- biocatalysis
About
Caravel is interested in partnerships or paid research deals with companies that would benefit from producing and/or engineering biocatalysts that are robust, reusable, endotoxin-free and amenable to use in harsher conditions (high temperatures, extremely high or low pHs). Caravels platform involves loading a target protein on the surface of bacterial spores- the most stable form of life on earth. This enables properties that are extended to the displayed protein that otherwise require a greater amount of upfront work for enzyme discovery. Our platform has already achieved an 18 month milestone in 6 months for a carbon capture project with an industrial partner.
On the discovery side, our platform enables screening of up to 10^6 variants a day, thereby speeding up current discovery campaigns. Beyond this, Caravel is also working on incorporation of non-standard amino acids into proteins that enable higher catalytic rates, increased stability and new chemistries.
Organisation
Similar opportunities
Expertise
Get Your Own Computational Protein Design Department
- Biotech, Pharma and Cosmetics
Ivan Ivanikov
CTO at AI-Driven Therapeutics
Leipzig, Germany
Expertise
Humanized multi-organoid models for translational drug discovery
Agne Vaitkeviciene
Business Development Director at abc biopply
Solothurn, Switzerland
Expertise
- Biotech, Pharma and Cosmetics
Elmeri Jokinen
CEO at Aurlide Oy
Turku, Finland